The Weekly Roundup: Conquering Diabetes (1.11.19)
From blood to sweat and tears, smart technology is changing the way diabetes is monitored and treated. Last spring, a continuous glucose monitor (CGM) that attached to the abdomen was the first of its kind approved by the FDA. Last summer, the development of a non-invasive smartwatch—which is purported to continuously and non-invasively monitor and track major chronic health risks, such as diabetes, cardiac arrhythmia, congestive heart failure, COPD, sleep apnea, and hypertension—was announced. Testing on a disposable skin patch is underway in Europe and the United States. Next up, perhaps a device that pinches the ear will make it through testing. It’s not always sunshine and rainbows, however. The afore-alluded-to smart lens that was the brainchild of a Google/Novartis team hit hard times and was abandoned late last year (see “tears” above). No one will easily forget the debacle at Theranos.
Still, until we can stem the tide of lives impacted by the disease with better pharmacy-assisted approaches to prevention, the pharmacy community will need to continue to stay up to date on the tools that can help with treatment. Recently, small-scale surveys are suggesting that, though the use of CGMs is still relatively low, practitioners believe it will rise to nearly half of type-2 diabetes patients within the next five years.
Here are a few other stories that might be of interest:
- Worse than Zika? A mosquito-borne virus found in the Rift Valley may pose an even greater threat to human fetuses.
- Bienvenido, National Hispanic Pharmacists Association (NHPA)! The new organization was launched to help pharmacists focus on health issues in the currently underrepresented Hispanic population.
- Keeping tabs on the data. Refill information seen as a key in understanding lapses in adherence for patients with chronic kidney disease.
- Here’s to hoping the US finds a way to follow suit. The National Health Service in the UK has tapped pharmacists as key contributors in delivering primary and community care over the next five years.
- Maybe we should start taking mental health more seriously? Study finds depression and anxiety to be as bad for long-term health as smoking and obesity.
[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So, we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at firstname.lastname@example.org.
Sign up now to receive the latest independent
pharmacy news, tips, and resources.
With a reach of 32 million lives, Accountable Care Organizations are good testing grounds for new concepts and programs to improve the quality and delivery of healthcare. More and more, those organizations are relying on pharmacists to help them deliver results. Physicians are recognizing&...
The lack of supply chain resilience in pharma is nothing new, and pharmacists and hospitals have been negotiating the problem for years. The task force set up in July that is focused on solving the problem has tossed out a range...